收费全文 | 1653篇 |
免费 | 69篇 |
国内免费 | 7篇 |
耳鼻咽喉 | 59篇 |
儿科学 | 60篇 |
妇产科学 | 74篇 |
基础医学 | 215篇 |
口腔科学 | 28篇 |
临床医学 | 84篇 |
内科学 | 344篇 |
皮肤病学 | 41篇 |
神经病学 | 148篇 |
特种医学 | 44篇 |
外科学 | 129篇 |
综合类 | 4篇 |
预防医学 | 112篇 |
眼科学 | 63篇 |
药学 | 256篇 |
中国医学 | 5篇 |
肿瘤学 | 63篇 |
2023年 | 10篇 |
2022年 | 13篇 |
2021年 | 65篇 |
2020年 | 32篇 |
2019年 | 64篇 |
2018年 | 88篇 |
2017年 | 57篇 |
2016年 | 68篇 |
2015年 | 49篇 |
2014年 | 79篇 |
2013年 | 111篇 |
2012年 | 108篇 |
2011年 | 130篇 |
2010年 | 92篇 |
2009年 | 39篇 |
2008年 | 82篇 |
2007年 | 75篇 |
2006年 | 60篇 |
2005年 | 53篇 |
2004年 | 66篇 |
2003年 | 78篇 |
2002年 | 56篇 |
2001年 | 30篇 |
2000年 | 15篇 |
1998年 | 2篇 |
1997年 | 4篇 |
1996年 | 4篇 |
1995年 | 3篇 |
1992年 | 2篇 |
1989年 | 5篇 |
1988年 | 4篇 |
1986年 | 5篇 |
1984年 | 3篇 |
1983年 | 2篇 |
1981年 | 2篇 |
1980年 | 4篇 |
1978年 | 3篇 |
1975年 | 3篇 |
1974年 | 3篇 |
1970年 | 2篇 |
1967年 | 2篇 |
1966年 | 2篇 |
1955年 | 29篇 |
1954年 | 99篇 |
1938年 | 2篇 |
1933年 | 3篇 |
1896年 | 2篇 |
1895年 | 1篇 |
1894年 | 1篇 |
1892年 | 1篇 |
Areas covered: We discuss factors determining phage activity and stability, which is relevant for the preparation and application of phage formulations with the highest therapeutic efficacy. Our article should be helpful for more insightful implementation of clinical trials, which could pave the way for successful phage therapy.
Expert opinion: The number of naturally occurring phages is practically unlimited and phages vary in their susceptibility to external factors. Modern methods offer engineering techniques which should lead to enhanced precision in phage delivery and anti-bacterial activity. Recent data suggesting that phages may also be used in treating nonbacterial infections as well as anti-inflammatory and immunomodulatory agents add further weight to such studies. It may be anticipated that different phage activities could have varying susceptibility to factors determining their actions. 相似文献
With continuously growing number of redo bariatric surgeries (RBS), it is necessary to look for factors determining success of redo-surgeries.
Patients and methodsA retrospective cohort study analyzed consecutive patients who underwent RBS in 12 referral bariatric centers in Poland from 2010 to 2020. The study included 529 patients. The efficacy endpoints were percentage of excessive weight loss (%EWL) and remission of hypertension (HT) and/or type 2 diabetes (T2D).
ResultsGroup 1: weight regain
Two hundred thirty-eight of 352 patients (67.6%) exceeded 50% EWL after RBS. The difference in body mass index (BMI) pre-RBS and lowest after primary procedure < 10.6 kg/m2 (OR 2.33, 95% CI: 1.43–3.80, p = 0.001) was independent factor contributing to bariatric success after RBS, i.e., > 50% EWL.
Group 2: insufficient weight loss
One hundred thirty of 177 patients (73.4%) exceeded 50% EWL after RBS. The difference in BMI pre-RBS and lowest after primary procedure (OR 0.76, 95% CI: 0.64–0.89, p = 0.001) was independent factors lowering odds for bariatric success.
Group 3: insufficient control of obesity-related diseases
Forty-three of 87 patients (49.4%) achieved remission of hypertension and/or type 2 diabetes. One Anastomosis Gastric Bypass (OAGB) as RBS was independent factor contributing to bariatric success (OR 7.23, 95% CI: 1.67–31.33, p = 0.008), i.e., complete remission of HT and/or T2D.
ConclusionsRBS is an effective method of treatment for obesity-related morbidity. Greater weight regain before RBS was minimizing odds for bariatric success in patients operated due to weight regain or insufficient weight loss. OAGB was associated with greater chance of complete remission of hypertension and/or diabetes.
Graphical abstract 相似文献